“GLP-1 analogues are reshaping diabetes and obesity care as innovation in drug delivery, expanding indications, and strong R&D pipelines drive explosive global demand.” Boston, Jan. 30, 2026 (GLOBE ...

Add Yahoo as a preferred source to see more of our stories on Google. MetaVia's DA-1726 is a dual OXM analogue agonist that functions as a glucagon-like peptide-1 receptor (GLP-1RA) and glucagon ...

In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with type 2 diabetes who use GLP-1 analogs ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...